GlassScriptPhysician profile
Roy Berenholtz
NPI 1215194261
$2,145.60
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $84.37 · 2021: $418 · 2022: $129 · 2023: $327 · 2024: $690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,017.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $516.23 | 2021-2023 | Senza |
| Amgen INC. | $482.54 | 2019 | |
| Axsome Therapeutics, INC. | $297.31 | 2023-2024 | Auvelity |
| Phathom Pharmaceuticals, INC. | $271.67 | 2024 | Voquezna |
| Abbott Laboratories | $270.81 | 2024 | Eterna, Proclaim |
| Heron Therapeutics, INC. | $122.43 | 2021 | |
| Salvin Dental Specialties, INC. | $45.30 | 2020 | |
| Nestle Healthcare Nutrition INC. | $39.37 | 2021-2022 | |
| Neotract INC. | $20.53 | 2020 | |
| Mycovia Pharmaceuticals, INC. | $18.94 | 2023 | Vivjoa |
| Takeda Pharmaceuticals U.S.A., INC. | $18.54 | 2020 | |
| Intercept Pharmaceuticals, INC. | $14.63 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.40 | 2022 | |
| Qol Medical, LLC | $12.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Berenholtz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.